Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

2.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.8K
Nursing Evaluation01:15

Nursing Evaluation

3.3K
The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126
Odds Ratio01:09

Odds Ratio

136
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
136
Role of Communication in the Nursing Process III: Evaluation and Documentation01:08

Role of Communication in the Nursing Process III: Evaluation and Documentation

1.3K
A successful patient outcome depends mainly on the evaluation stage of the nursing process. Evaluation determines effectiveness by reviewing what was done previously after the completion of nursing interventions. Every time a healthcare professional steps in or administers treatment, they must reassess or evaluate the action to ensure the intended result. During the evaluation phase, there are three probable patient outcomes:
1.3K
Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation01:20

Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation

1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nonfactor Replacement Treatment and Surgery in Haemophilia: Evidence From the Literature and Selected Clinical Cases.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study.

Blood advances·2026
Same author

International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD).

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Real-World Experience with Eptacog Beta for On-Label and Off-Label Indications: The Spanish Experience.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Supporting Patient-Centred Decisions on Gene Therapy for Haemophilia A: A Conceptual Model.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Age and sex influence bleeding score in mild VWF deficiency.

Blood advances·2025

Related Experiment Video

Updated: Jun 30, 2025

Using Learning Outcome Measures to assess Doctoral Nursing Education
10:07

Using Learning Outcome Measures to assess Doctoral Nursing Education

Published on: June 21, 2010

19.0K

Outcomes and outcome measures.

Giancarlo Castaman1, Victor Jimenez-Yuste2, Samanta Gouw3

  • 1Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, Florence, Italy.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|March 20, 2024
PubMed
Summary
This summary is machine-generated.

Advances in haemophilia treatment improve life expectancy and quality of life. New methods are needed to assess treatment efficacy using both clinical data and patient-reported outcomes (PROs), especially for women with bleeding disorders.

Keywords:
annualized bleeding ratehaemophiliajoint healthoutcomespatient‐reported outcomesquality of life

More Related Videos

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K

Related Experiment Videos

Last Updated: Jun 30, 2025

Using Learning Outcome Measures to assess Doctoral Nursing Education
10:07

Using Learning Outcome Measures to assess Doctoral Nursing Education

Published on: June 21, 2010

19.0K
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.4K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.0K

Area of Science:

  • Hematology
  • Patient-Reported Outcomes Research

Background:

  • Haemophilia treatment advances have improved life expectancy and quality of life in high-income countries.
  • Current treatment efficacy assessment focuses on clinical parameters, but patient perspectives are increasingly important.

Purpose of the Study:

  • To highlight the need for novel parameters to assess haemophilia treatment efficacy.
  • To emphasize the integration of objective clinical methodologies with patient-reported outcomes (PROs).
  • To address the specific needs and outcomes for women with congenital bleeding disorders.

Main Methods:

  • Review of current methodologies for assessing treatment efficacy in haemophilia.
  • Analysis of existing patient-reported outcome (PRO) instruments and their limitations.
  • Identification of key outcomes relevant to congenital bleeding disorders, including women-specific concerns.

Main Results:

  • Objective clinical assessments and PROs are crucial for comprehensive treatment evaluation.
  • Existing PRO instruments require improvement and validation for personalized care.
  • There is a growing recognition of unique outcomes for women with bleeding disorders, necessitating tailored assessment tools.

Conclusions:

  • Further development and validation of PRO tools are essential for personalized care in bleeding disorders.
  • Incorporating these comprehensive outcome measures into regulatory approval processes for novel treatments needs to be established.